![David R. Liu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David R. Liu
Career history of David R. Liu
Former positions of David R. Liu
Companies | Position | Start | End |
---|---|---|---|
TERNS PHARMACEUTICALS, INC. | Director/Board Member | - | - |
Chroma Medicine, Inc.
![]() Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Founder | 01/01/2020 | - |
BEAM THERAPEUTICS INC. | Founder | 25/01/2017 | - |
Statistics
International
United States | 4 |
Operational
Founder | 2 |
Director/Board Member | 1 |
Sectoral
Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
BEAM THERAPEUTICS INC. | Health Technology |
TERNS PHARMACEUTICALS, INC. | Health Technology |
Private companies | 1 |
---|---|
Chroma Medicine, Inc.
![]() Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Health Technology |
- Stock Market
- Insiders
- David R. Liu
- Experience